These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24382892)

  • 1. Academia and big pharma United.
    Ljunggren HG
    Sci Transl Med; 2014 Jan; 6(217):217ed1. PubMed ID: 24382892
    [No Abstract]   [Full Text] [Related]  

  • 2. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 4. Academic medical centers and the pharmaceutical industry.
    Del Parigi A
    Clin Pharmacol Ther; 2010 Oct; 88(4):464-5. PubMed ID: 20703224
    [No Abstract]   [Full Text] [Related]  

  • 5. Collaborating with industry--choices for the academic medical center.
    Moses H; Braunwald E; Martin JB; Thier SO
    N Engl J Med; 2002 Oct; 347(17):1371-5. PubMed ID: 12397200
    [No Abstract]   [Full Text] [Related]  

  • 6. Principles and considerations for effective academia-industry collaboration in pharmacoepidemiology.
    Ephross SA; Mitchell AA; Sacks S; Straus W; Stürmer T
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1153-1156. PubMed ID: 30232825
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of academic medical centers in advancing regulatory science.
    Meyer RJ
    Clin Pharmacol Ther; 2014 May; 95(5):471-3. PubMed ID: 24747233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Millennium collaborates with leading clinical centers.
    Hodgson J
    Nat Biotechnol; 1998 Oct; 16(10):897. PubMed ID: 9788331
    [No Abstract]   [Full Text] [Related]  

  • 9. Academic partnerships 2015.
    Huggett B
    Nat Biotechnol; 2016 Apr; 34(4):372. PubMed ID: 27054985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of academic medicine for innovations in development of drugs and biomedicine technology].
    Manns MP
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1993-4. PubMed ID: 24065403
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
    Mavilio F
    Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.
    van de Kerkhof PCM
    J Invest Dermatol; 2020 Mar; 140(3):524-526. PubMed ID: 31945346
    [No Abstract]   [Full Text] [Related]  

  • 13. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaboration between academia and pharma to bring new therapies to market more important than ever.
    Caffrey MK
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E14. PubMed ID: 25764579
    [No Abstract]   [Full Text] [Related]  

  • 15. The Alcon Research Institute. A model for interaction between the pharmaceutical industry and academic medicine.
    Leibowitz HM
    Arch Ophthalmol; 1993 Aug; 111(8):1039-40. PubMed ID: 8352685
    [No Abstract]   [Full Text] [Related]  

  • 16. Translational research: moving discovery to practice.
    Zerhouni EA
    Clin Pharmacol Ther; 2007 Jan; 81(1):126-8. PubMed ID: 17186011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is academic medicine for sale?
    Angell M
    N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191
    [No Abstract]   [Full Text] [Related]  

  • 18. The UK's NHS and pharma: from schism to symbiosis.
    Horton R
    Lancet; 2009 Feb; 373(9662):435-6. PubMed ID: 19200902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 20. Institutional review boards and collaborations between academia and industry: some counterproductive policies and practices.
    Levine RJ
    Circulation; 1985 Aug; 72(2 Pt 2):I48-50. PubMed ID: 4006159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.